STOCK TITAN

Health In Tech grants chairman 800K acquisition-linked shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Health In Tech, Inc. Executive Chairman Tim Donald Johnson reported restricted stock awards on November 10, 2026. The 650,000 Class A shares were issued following stockholder approval and vest in 12 monthly installments from November 15, 2026; 800,000 Class A shares vest upon an acquisition closing by December 31, 2028, subject to continued service. Four other Class A awards of 600,000, 600,000, 200,000 and 200,000 shares depend, respectively, on market capitalization measured by 10-day VWAP exceeding $150 million by April 30, 2028, $300 million by December 31, 2028, $500 million by December 31, 2029, and $1 billion by December 31, 2031. They vest in 12 monthly installments subject to continued service. The 200,000 Class B shares follow the $150 million condition. All unvested awards vest in full upon a Change in Control.

Insider Johnson Tim Donald
Role Executive Chairman
Type Security Shares Price Value
Grant/Award Class A Common Stock F1 650,000 $0.00 $0.00
Grant/Award Class A Common Stock F2 800,000 $0.00 $0.00
Grant/Award Class A Common Stock F3 600,000 $0.00 $0.00
Grant/Award Class A Common Stock F4 600,000 $0.00 $0.00
Grant/Award Class A Common Stock F5 200,000 $0.00 $0.00
Grant/Award Class A Common Stock F6, F8 200,000 $0.00 $0.00
Grant/Award Class B Common Stock F7, F9 200,000 $0.00 $0.00
Holdings After Transaction: Class A Common Stock — 26,201,298 shares (Direct); Class B Common Stock — 9,200,000 shares (Direct)
Holdings Before and After: Class A Common Stock, 23,151,298 to 26,201,298 shares (Direct); Class B Common Stock, 9,000,000 to 9,200,000 shares (Direct)
Footnotes (9)
  1. F1. Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.
  2. F2. Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.
  3. F3. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  4. F4. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  5. F5. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  6. F6. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
  7. F7. Represents restricted shares of Class B Common Stock on the terms described in footnote (3).
  8. F8. Includes 3,663,279 restricted shares of Class A Common Stock and 22,538,019 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.
  9. F9. All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).
Class A restricted shares awarded 650,000 shares Reported November 10, 2026; vest in 12 monthly installments beginning November 15, 2026.
Class A restricted shares awarded 800,000 shares Reported November 10, 2026; vest upon an acquisition closing by December 31, 2028, subject to continued service.
Class A restricted shares awarded 600,000 shares Reported November 10, 2026; tied to the $150 million market-capitalization threshold.
Class A restricted shares awarded 600,000 shares Reported November 10, 2026; tied to the $300 million market-capitalization threshold.
Class A restricted shares awarded 200,000 shares Reported November 10, 2026; tied to the $500 million market-capitalization threshold.
Class A restricted shares awarded 200,000 shares Reported November 10, 2026; tied to the $1 billion market-capitalization threshold.
Class B restricted shares awarded 200,000 shares Reported November 10, 2026; follows the $150 million market-capitalization condition.
Class B shares held following transaction 9,200,000 shares Direct holdings reported after the November 10, 2026 award.
restricted shares financial
"Represents restricted shares of Class A Common Stock"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
10-day VWAP financial
"market capitalization (measured by 10-day VWAP)"
10-day VWAP is the average price at which a stock traded over the past ten trading days, weighted by the number of shares exchanged at each price so bigger trades count more. Investors use it like a benchmark or reference line—similar to checking the average speed on a ten-day trip weighted by how long you traveled at each speed—to judge whether current prices are fair, to time trades, and to spot short-term trends or unusual activity.
Change in Control financial
"vest in full upon a Change in Control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Equity Incentive Plan financial
"under the Health In Tech, Inc. Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Restricted Stock Award Agreement financial
"pursuant to a Restricted Stock Award Agreement"
A restricted stock award agreement is a legal contract that grants someone company shares that are subject to limits — for example, they may only become fully owned after working at the company for a set time, meeting performance goals, or otherwise satisfying conditions. For investors, these agreements matter because they shape insider incentives, future share dilution when restrictions lift, and company compensation costs; think of it like a gift locked in a box that opens only after certain conditions are met.
market capitalization financial
"the Issuer's market capitalization"
Market capitalization is the total market value of a company’s outstanding shares, calculated by multiplying the current share price by the number of shares issued. It gives a quick snapshot of a company’s size and how investors value it, influencing perceived risk, index membership, and roughly how much it might cost to buy the whole company — like using a sticker price to compare the relative size and price of different houses.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the conditions on Tim Donald Johnson’s 800,000-share HIT award?

The 800,000 restricted Class A shares vest in full only if an acquisition by Health In Tech closes on or before December 31, 2028, and Johnson continues service through closing; otherwise, the shares are forfeited without consideration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Johnson Tim Donald

(Last)(First)(Middle)
701 S. COLORADO AVE, SUITE 1

(Street)
STUART FLORIDA 34994

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/10/2026A650,000(1)A$023,801,298D
Class A Common Stock11/10/2026A800,000(2)A$024,601,298D
Class A Common Stock11/10/2026A600,000(3)A$025,201,298D
Class A Common Stock11/10/2026A600,000(4)A$025,801,298D
Class A Common Stock11/10/2026A200,000(5)A$026,001,298D
Class A Common Stock11/10/2026A200,000(6)A$026,201,298(8)D
Class B Common Stock11/10/2026A200,000(7)A$09,200,000(9)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted shares of Class A Common Stock granted under the Health In Tech, Inc. Equity Incentive Plan (the "Plan") pursuant to a Restricted Stock Award Agreement dated as of October 20, 2026. The grant was contingent upon, and the shares were issued upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares vest in twelve equal monthly installments commencing November 15, 2026, subject to continued service through each vesting date.
2. Represents restricted shares of Class A Common Stock that vest in full upon the closing of an acquisition by the Issuer on or before December 31, 2028, subject to continued service through such closing, and are otherwise forfeited without consideration.
3. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $150 million on or before April 30, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
4. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
5. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $500 million on or before December 31, 2029 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
6. Represents restricted shares of Class A Common Stock that are forfeited without consideration unless the Issuer's market capitalization (measured by 10-day VWAP) exceeds $1 billion on or before December 31, 2031 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service, commencing on the 15th of the month if the Achievement Date is before the 15th, or otherwise on the 1st of the next month.
7. Represents restricted shares of Class B Common Stock on the terms described in footnote (3).
8. Includes 3,663,279 restricted shares of Class A Common Stock and 22,538,019 unrestricted shares of Class A Common Stock. Excludes 200,000 restricted shares of Class B Common Stock, 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.
9. All unvested restricted shares reported herein vest in full upon a Change in Control (as defined in the Plan).
/s/ Lori Babcock, as attorney-in-fact for Tim Johnson11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading